Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.
A skin brightening product that addresses the appearance of skin discoloration
CARLSBAD, Calif., March 4, 2013 /PRNewswire/ -- SkinMedica®, the fastest growing professional skin care brand for the past six years, introduces a revolution in skin brightening. SkinMedica® Lytera™ Skin Brightening Complex is a hydroquinone-free skin brightening product that reduces the appearance of skin discoloration and dark spots. In clinical studies, Lytera demonstrated similar efficacy when compared to 4% hydroquinone.
Featuring a proprietary blend of ingredients, SkinMedica® Lytera™ Skin Brightening Complex works to brighten and even skin tone by reducing the appearance of dark spots and skin discoloration. This luxurious formula contains highly effective antioxidants which help to reveal a smooth, luminous complexion-a naturally beautiful you.
"Recent advances have given numerous options for those seeking anti-aging therapies. However, treatment of dark patches and hyperpigmentation is just as important in rejuvenation as fine lines and wrinkles, and there is a lack of truly efficacious treatments available in this arena," says board-certified dermatologist, Dr. Annie Chiu. "The strong clinical results and multi-modal formulation of Lytera™ Skin Brightening Complex makes it a unique and vital addition to any brightening regimen" added Dr. Chiu.
In a recently published clinical study*:
SkinMedica® Lytera™ Skin Brightening Complex ($125) and the SkinMedica® Skin Brightening System ($250) featuring Lytera™ Skin Brightening Complex, Facial Cleanser, Tri-Retinol Complex ES™ and Daily Physical Defense™ SPF 30+ Sunscreen is now available exclusively through licensed physicians and medically supervised spas. Visit skinmedica.com/lytera for locations.
*Reference: Makino ET, et al. J Drugs Dermatol. 2012; 11(12):1478-1482.
©2012 PR Newswire. All Rights Reserved.